Literature DB >> 3803464

Multiple NADPH-producing pathways control glutathione (GSH) content in retina.

B S Winkler, N DeSantis, F Solomon.   

Abstract

Glutathione (GSH), together with NADPH-producing pathways and glutathione reductase, provides a defense system against oxidants. Oxidation of GSH causes stimulation of the hexose monophosphate shunt and increased production of NADPH. We have asked if hexose monophosphate shunt activity is required for the recovery of GSH following exposure of the isolated rat retina to an oxidant. Hexose monophosphate shunt activity was decreased by depleting the retina of hexose stores, before exposing the tissue to diamide (0.04-1.0mM), an oxidant for GSH, for 30 min. After exposure, retinas were transferred to either glucose-containing or glucose-free recovery medium for an additional 30 min. Control retinas kept in glucose-free, oxygenated medium (no diamide) for 90-120 min maintained GSH at 90% of the value found in retinas incubated with glucose. After exposure of hexose-depleted retinas to 0.4 mM diamide, a nearly 90% decrease in GSH was observed. When the oxidant was removed, the level of GSH returned to more than 80% of the control value in the presence or absence of glucose. In contrast, no recovery of GSH was observed after diamide treatment if the retinas were transferred to ice-cold (1-5 degrees C) media with or without glucose or if the retinas were pre-treated with 2 mM 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) to inhibit glutathione reductase. Measurements of two NADPH-producing cytosolic enzymes, namely NADP+-dependent malic enzyme and NADP+-dependent isocitrate dehydrogenase, revealed high activities. Optimum production of NADPH from malic enzyme was 0.90 nmol NADPH produced min-1 per retina, while with isocitrate dehydrogenase the average rate was 6.9 nmol NADPH produced min-1 per retina. We suggest that these enzymes together with a long-lived endogenous substrate (probably glutamate) are responsible for the recovery of GSH in hexose-depleted retinas. The present results suggest that more than one NADPH-producing system is capable of controlling the GSH concentration in retina. Studies that have focused on the hexose monophosphate shunt pathway as the sole source of NADPH for glutathione reductase in retina and other tissues may require re-evaluation depending on the overall metabolic capacity and substrate utilization of the particular tissue. Thus, the present findings are significant not only with respect to the retina but also for other tissues whose metabolic characteristics are similar to those found in the retina.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3803464     DOI: 10.1016/s0014-4835(86)80013-6

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  32 in total

Review 1.  Alterations of metabolic genes and metabolites in cancer.

Authors:  Eric K Oermann; Jing Wu; Kun-Liang Guan; Yue Xiong
Journal:  Semin Cell Dev Biol       Date:  2012-01-28       Impact factor: 7.727

2.  Mitochondrial NADP+-Dependent Isocitrate Dehydrogenase Deficiency Exacerbates Mitochondrial and Cell Damage after Kidney Ischemia-Reperfusion Injury.

Authors:  Sang Jun Han; Hee-Seong Jang; Mi Ra Noh; Jinu Kim; Min Jung Kong; Jee In Kim; Jeen-Woo Park; Kwon Moo Park
Journal:  J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 10.121

3.  Liraglutide attenuates partial warm ischemia-reperfusion injury in rat livers.

Authors:  Ahmed A Abdelsameea; Noha A T Abbas; Samar M Abdel Raouf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-16       Impact factor: 3.000

4.  Low tumor glutathione level as a sensitivity marker for glutamate-cysteine ligase inhibitors.

Authors:  Satoru Nishizawa; Hideo Araki; Yoshinori Ishikawa; Satoshi Kitazawa; Akito Hata; Tomoyoshi Soga; Takahito Hara
Journal:  Oncol Lett       Date:  2018-04-10       Impact factor: 2.967

5.  Luteolinidin Protects the Postischemic Heart through CD38 Inhibition with Preservation of NAD(P)(H).

Authors:  James Boslett; Craig Hemann; Yong Juan Zhao; Hon-Cheung Lee; Jay L Zweier
Journal:  J Pharmacol Exp Ther       Date:  2017-01-20       Impact factor: 4.030

6.  DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma.

Authors:  Brock C Christensen; Ashley A Smith; Shichun Zheng; Devin C Koestler; E Andres Houseman; Carmen J Marsit; Joseph L Wiemels; Heather H Nelson; Margaret R Karagas; Margaret R Wrensch; Karl T Kelsey; John K Wiencke
Journal:  J Natl Cancer Inst       Date:  2010-12-16       Impact factor: 13.506

7.  Mitochondria contribute to NADPH generation in mouse rod photoreceptors.

Authors:  Leopold Adler; Chunhe Chen; Yiannis Koutalos
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

8.  Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.

Authors:  Shimin Zhao; Yan Lin; Wei Xu; Wenqing Jiang; Zhengyu Zha; Pu Wang; Wei Yu; Zhiqiang Li; Lingling Gong; Yingjie Peng; Jianping Ding; Qunying Lei; Kun-Liang Guan; Yue Xiong
Journal:  Science       Date:  2009-04-10       Impact factor: 47.728

Review 9.  IDH mutations in human glioma.

Authors:  Won Kim; Linda M Liau
Journal:  Neurosurg Clin N Am       Date:  2012-05-31       Impact factor: 2.509

10.  Expression of pyruvate carboxylase in cultured oligodendroglial, microglial and ependymal cells.

Authors:  Radovan Murin; Marija Cesar; Bhavani S Kowtharapu; Stephan Verleysdonk; Bernd Hamprecht
Journal:  Neurochem Res       Date:  2008-08-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.